HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Pediatric Center of Excellence in Nephrology
Children's Hospital of Philadelphia established the Pediatric Center of Excellence in Nephrology (PCEN) with funding from the National Institute of Diabetes and Digestive and Kidney Diseases to promote and develop clinical trial research with a focus on nephrology. CHOP PCEN's mission is to increase efficiency and reduce barriers to collaborative clinical trials by serving as a widely available resource to all clinicians, researchers, and investigators helping children with kidney disease. Its Cores and Programs aim to increase awareness of nephrology research, the impact of the research, and the robustness of its clinical trials.
Along with the other two NIH-funded PCENs, CHOP is excited to announce the release of a joint RFA for the Pilot and Feasibility Program! The goal for this RFA is to fund one-year pediatric kidney-related research projects that generate preliminary data to support future research applications. CHOP is specifically interested in funding research that increases efficiency and reduces barriers to clinical trials. Preference is given to applicants utilizing one of CHOP PCEN’s cores: the Learning Health System Core or the Molecular Precision Nephrology Core.
Does this sound like the perfect opportunity for you? Find out more details in the RFA!
Important Dates
Letters of Intent: Wednesday, February 1, 2023 at 5:00 p.m. EST
Invitations to submit Full Applications: February 15, 2023.
Full Applications: Tuesday, March 7, 2023 at 5:00 p.m. EST
Awards: May 2023
Research Highlights
Bone Quality and Vascular Health in Adolescents with Urinary Stone Disease
Increasingly recognized as a chronic systemic disorder with skeletal and vascular morbidity, urinary stone disease is increasing disproportionately among adolescents, making it critical to understand its impact on bone and vascular health in this population. Read more.
Derivation and Validation of Imaging Biomarkers for CKD Progression
Biomarkers are needed that can identify children with congenital anomalies of the kidneys and urinary tract early in life who are at high risk of future chronic kidney disease progression and help guide clinical trials. Read more.
